JIUYUAN GENE (02566) Plans to Repurchase Shares with Up to RMB100 Million

Stock News12-02

JIUYUAN GENE (02566) announced that its board of directors resolved on December 2, 2025, to repurchase up to approximately 10.9097 million H shares in the open market using no more than RMB100 million of its own funds, subject to market conditions. The repurchases will be conducted under the share buyback authorization from the date of this announcement until its expiration.

The actual repurchase price per H share in each transaction must not exceed a premium of 5% or more above the average closing price of the H shares over the five trading days immediately preceding each repurchase. The repurchased H shares may be canceled, held as treasury shares, or used for employee incentive plans.

The company currently maintains strong cash flow and stable financial conditions, which support its ongoing business development needs. The board believes that the current trading price does not fully reflect the company's intrinsic value and business prospects. The share repurchase demonstrates confidence in the company's growth potential and is expected to benefit shareholders by creating long-term value.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1148878110?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-12-02 18:38","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1148878110","market":"fut","top_or_hot":-1,"title":"JIUYUAN GENE (02566) Plans to Repurchase Shares with Up to RMB100 Million","media":"Stock News","content":"<p>JIUYUAN GENE (02566) announced that its board of directors resolved on December 2, 2025, to repurchase up to approximately 10.9097 million H shares in the open market using no more than RMB100 million of its own funds, subject to market conditions. The repurchases will be conducted under the share buyback authorization from the date of this announcement until its expiration.</p>\n<p>The actual repurchase price per H share in each transaction must not exceed a premium of 5% or more above the average closing price of the H shares over the five trading days immediately preceding each repurchase. The repurchased H shares may be canceled, held as treasury shares, or used for employee incentive plans.</p>\n<p>The company currently maintains strong cash flow and stable financial conditions, which support its ongoing business development needs. The board believes that the current trading price does not fully reflect the company's intrinsic value and business prospects. The share repurchase demonstrates confidence in the company's growth potential and is expected to benefit shareholders by creating long-term value.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>JIUYUAN GENE (02566) Plans to Repurchase Shares with Up to RMB100 Million</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nJIUYUAN GENE (02566) Plans to Repurchase Shares with Up to RMB100 Million\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036600163\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock News </p>\n<p class=\"h-time\">2025-12-02 18:38</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>JIUYUAN GENE (02566) announced that its board of directors resolved on December 2, 2025, to repurchase up to approximately 10.9097 million H shares in the open market using no more than RMB100 million of its own funds, subject to market conditions. The repurchases will be conducted under the share buyback authorization from the date of this announcement until its expiration.</p>\n<p>The actual repurchase price per H share in each transaction must not exceed a premium of 5% or more above the average closing price of the H shares over the five trading days immediately preceding each repurchase. The repurchased H shares may be canceled, held as treasury shares, or used for employee incentive plans.</p>\n<p>The company currently maintains strong cash flow and stable financial conditions, which support its ongoing business development needs. The board believes that the current trading price does not fully reflect the company's intrinsic value and business prospects. The share repurchase demonstrates confidence in the company's growth potential and is expected to benefit shareholders by creating long-term value.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK1161","symbol_name":"生物科技","start_time":0,"source_url":"","article_id":"1148878110","we_media_id":"1036600163","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1148878110","pubTimestamp":1764671894,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Stock News","introduction":"Global Stock News First-Time Broadcast","home_visible":1,"id":"1036600163","head_image":"https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a"},"summary":"JIUYUAN GENE (02566) announced that its board of directors resolved on December 2, 2025, to repurchase up to approximately 10.9097 million H shares in the open market using no more than RMB100...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK1161":"生物科技","02566":"九源基因"},"translate_title":"久远基因(02566)拟不超1亿元回购股份","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02566":1},"content_text":"JIUYUAN GENE (02566) announced that its board of directors resolved on December 2, 2025, to repurchase up to approximately 10.9097 million H shares in the open market using no more than RMB100 million of its own funds, subject to market conditions. The repurchases will be conducted under the share buyback authorization from the date of this announcement until its expiration.\nThe actual repurchase price per H share in each transaction must not exceed a premium of 5% or more above the average closing price of the H shares over the five trading days immediately preceding each repurchase. The repurchased H shares may be canceled, held as treasury shares, or used for employee incentive plans.\nThe company currently maintains strong cash flow and stable financial conditions, which support its ongoing business development needs. The board believes that the current trading price does not fully reflect the company's intrinsic value and business prospects. The share repurchase demonstrates confidence in the company's growth potential and is expected to benefit shareholders by creating long-term value.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"shareholding","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.11","shortVersion":"4.35.11","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1148878110","isCrawlerRequest":true}